0001209191-20-035738.txt : 20200610 0001209191-20-035738.hdr.sgml : 20200610 20200610204930 ACCESSION NUMBER: 0001209191-20-035738 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200608 FILED AS OF DATE: 20200610 DATE AS OF CHANGE: 20200610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAVIOLETTE PAUL A CENTRAL INDEX KEY: 0001191249 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 20955972 MAIL ADDRESS: STREET 1: ONE BOSTON PLACE STREET 2: 201 WASHINGTON STREET, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX, INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX INC. DATE OF NAME CHANGE: 20131210 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-08 0 0000876378 TRANSENTERIX, INC. TRXC 0001191249 LAVIOLETTE PAUL A ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108 1 0 0 0 Common Stock 2020-06-08 4 A 0 8901 A 8901 D Common Stock 2020-06-08 4 A 0 22500 A 31401 D Stock Option 0.82 2020-06-08 4 A 0 31250 0.00 A 2027-06-08 Common Stock 31250 31250 D Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock. The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the Reporting Person remains in continuous service during the vesting period. The Reporting Person has assigned shares issued from prior grants of restricted stock units to SV Health Investors in accordance with its operating agreement and is expected to transfer the shares underlying this reported award upon vesting. The stock options will vest 25% on each of September 8, 2020, December 8, 2020, March 8, 2021 and June 8, 2021, provided that if the date of the 2021 annual meeting of stockholders is earlier, the last vesting occurs on the date of the annual meeting. Subject to acceleration of vesting in full upon consummation of a change in control of the Registrant. /s/ Joshua Weingard, as attorney-in-fact for Paul A. LaViolette 2020-06-10